SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $23,000 | – | 8,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
| 1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
| Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
| CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
| CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
| J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
| Renaissance Technologies | 591,086 | $554,000 | 0.00% |